claude chelala

claude chelala

Queen Mary University of London

H-index: 47

Europe-United Kingdom

About claude chelala

claude chelala, With an exceptional h-index of 47 and a recent h-index of 35 (since 2020), a distinguished researcher at Queen Mary University of London,

His recent articles reflect a diverse array of research interests and contributions to the field:

Prevalence of multimorbidity in survivors of 28 cancer sites: an English nationwide cross-sectional study

Phenotypic plasticity mediates colorectal cancer metastasis

A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer

Dynamic Biobanking for Advancing Breast Cancer Research

541 Gene set enrichment analysis identifies biological networks associated with skin aging in a large Japanese population: Data from the Nagahama cohort

Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

Chairwomen: Diagnostic studies for pancreatic cancer

claude chelala Information

University

Position

Professor of Bioinformatics Barts Cancer Institute

Citations(all)

9612

Citations(since 2020)

5339

Cited By

6906

hIndex(all)

47

hIndex(since 2020)

35

i10Index(all)

85

i10Index(since 2020)

71

Email

University Profile Page

Queen Mary University of London

Google Scholar

View Google Scholar Profile

Top articles of claude chelala

Title

Journal

Author(s)

Publication Date

Prevalence of multimorbidity in survivors of 28 cancer sites: an English nationwide cross-sectional study

American Journal of Cancer Research

Tahania A Ahmad

Abu ZM Dayem Ullah

Claude Chelala

Dipesh P Gopal

Fabiola Eto

...

2024

Phenotypic plasticity mediates colorectal cancer metastasis

Mirjana Efremova

Samuel Ogden

Nasrine Metic

Elise Smith

Alison Berner

...

2024/2/1

A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

Pharmacological Reports

Melissa M Phillips

Iuliia Pavlyk

Michael Allen

Essam Ghazaly

Rosalind Cutts

...

2023/6

Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer

Journal for Immunotherapy of Cancer

Renato Brito Baleeiro

Peng Liu

Louisa S Chard Dunmall

Carmela Di Gioia

Ai Nagano

...

2023

Dynamic Biobanking for Advancing Breast Cancer Research

Journal of Personalized Medicine

Maryam Abdollahyan

Emanuela Gadaleta

Millahat Asif

Jorge Oscanoa

Rachel Barrow-McGee

...

2023/2

541 Gene set enrichment analysis identifies biological networks associated with skin aging in a large Japanese population: Data from the Nagahama cohort

Journal of Investigative Dermatology

J Latreille

G Thorn

R Jdid

G Gendronneau

Y Tabara

...

2023/5/1

Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesothelioma

Pharmacological Reports

Melissa M Phillips

Iuliia Pavlyk

Michael Allen

Essam Ghazaly

Rosalind Cutts

...

2023

Chairwomen: Diagnostic studies for pancreatic cancer

Pancreatology

Claude Chelala

Eithne Costello-Goldring

2023/6/1

Multimorbidity in people living with and beyond cancer: a scoping review

Tahania A Ahmad

Dipesh P Gopal

Claude Chelala

Abu ZM Dayem Ullah

Stephanie JC Taylor

2023

902 Development of a web-based platform to facilitate research to uncover the skin ageing mechanism

Journal of Investigative Dermatology

J Oscanoa

J Latreille

S Le Clerc

C Muther

G Thorn

...

2023/5/1

Field cancerization in breast cancer

Emanuela Gadaleta

Graeme J Thorn

Helen Ross‐Adams

Louise J Jones

Claude Chelala

2022/7

Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control Study

Cancers

Mohamed Zardab

Vickna Balarajah

Abhirup Banerjee

Konstantinos Stasinos

Amina Saad

...

2022/12/31

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer

BMC cancer

Lavanya Sivapalan

Graeme J Thorn

Emanuela Gadaleta

Hemant M Kocher

Helen Ross-Adams

...

2022/4/7

The molecular landscape of pancreatic ductal adenocarcinoma

L Sivapalan

HM Kocher

H Ross-Adams

C Chelala

2022/11/1

Code of practice needed to ensure good use is made of tissue samples donated by clinical trial participants: a biobank perspective

The Lancet Oncology

Valerie Speirs

Angela Cox

Claude Chelala

Jacqueline A James

Richard A Adams

...

2022/5/1

MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy

OncoImmunology

Renato B Baleeiro

Christian J Bouwens

Peng Liu

Carmela Di Gioia

Louisa S Chard Dunmall

...

2022/12/31

A network analysis and literature review of clinical Natural Language Processing (NLP): the United Kingdom landscape from 2007 to 2022

Honghan Wu

Minhong Wang

Jinge Wu

Farah Francis

Yun-Hsuan Chang

...

2022/10/31

A biobank perspective on use of tissue samples donated by trial participants

The Lancet Oncology

Valerie Speirs

Angela Cox

Claude Chelala

Jacqueline A James

Richard A Adams

...

2022/5/1

Expression Profile of Myoepithelial Cells in DCIS: Do They Change From Protective Angels to Wicked Witches?

Applied Immunohistochemistry & Molecular Morphology

Marwa M Dawoud

Dylan T Jones

Claude Chelala

Asmaa G Abdou

Sally A Dreger

...

2022/7/1

A survey on clinical natural language processing in the United Kingdom from 2007 to 2022

Honghan Wu

Minhong Wang

Jinge Wu

Farah Francis

Yun-Hsuan Chang

...

2022/12/21

See List of Professors in claude chelala University(Queen Mary University of London)